MINGYANG TECHNOLOGY
837663
Shanghai Weihong Electronic Technology
300508
Shenzhen Intellifusion Technologies
688343
Est Tools Co., Ltd.
300488
Jiangyin Pivot Automotive Products
301181
CN Stock MarketDetailed Quotes
002940 Zhejiang Anglikang Pharmaceutical
- 13.34
- -0.17-1.26%
Market Closed Feb 25 15:00 CST
2.69BMarket Cap34.29P/E (TTM)
13.51High13.33Low14.16KlotVolume13.40Open13.51Pre Close19.00MTurnover0.76%Turnover Ratio19.45P/E (Static)201.73MShares19.1252wk High1.78P/B2.47BFloat Cap11.8252wk Low14.86Limit Up185.28MShs Float32.41Historical High12.16Limit Down1.33%Amplitude11.16Historical Low0.21Dividend TTM13.42Avg Price8.40KlotAsk1.57%Div YieldTTM100Lot Size5.62KlotBid
Zhejiang Anglikang Pharmaceutical News
Onlikon: Announcement on acceptance of ALK-N001 clinical trial applications for innovative drug injections
Onlikon: Announcement on the subsidiary finasteride API obtaining approval notice for the marketing application of chemical raw materials
Onlikon: Announcement on the Change of Continued Supervisory Sponsor Representative
Onlikon: Announcement on Subsidiaries Participating in Pharmaceutical Volume Procurement of Sanming Procurement Alliance to be selected
Onlikang: Announcement on the Company\'s Participation in the Tenth Batch of National Centralized Drug Procurement and Proposed Selection
Onlikang: Announcement on the company\'s cooperative products to be selected for the tenth batch of centralized procurement of national drugs
Onlikon: Announcement on Subsidiaries Obtaining Approval Numbers for Veterinary Drug Products
Onlikon: Notice on Obtaining a Notice of Approval for Supplementary Applications for Chemical Ingredients
Onlikon: Announcement on the subsidiary\'s renewal of the “Veterinary Drug GMP Certificate” and passing the GMP compliance inspection
Onlikon: Announcement on the actual controller\'s renewal of the concerted action agreement
Onlikon: Announcement on Subsidiaries Obtaining Drug Registration Certificates
Onlikon: Announcement on the extension of the term of the first employee stock ownership plan
Onlikang: Announcement on the completion of the registration of industrial and commercial changes by the subsidiary Jiangxi Chundi Biotechnology Co., Ltd.
Onlikon: Announcement on Continued Supervision of Changes in Sponsor Entities
Onlikang: Announcement on the purchase of part of the minority shares of Jiangxi Chundi Biotechnology Co., Ltd. by its subsidiary Hunan Kerui Biopharmaceutical Co., Ltd.
Onlykang: Summary table of non-operating capital usage and other related capital transactions for the half year
Onlikon: 2024 Semi-Annual Financial Report
Zhejiang Anglikang Pharmaceutical: Announcement on Pharmaceutical Registration Approval for Collaborative Product Lanthanum Carbonate Chewable Tablets
Zhejiang Anglikang Pharmaceutical: Announcement Regarding Changes to the Business Scope and Revision of the Articles of Association and Completion of Industrial and Commercial Registration Changes.
Zhejiang Anglikang Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders